HR 2003
113th Congress
House
Health
Consumer affairs
Drug safety, medical device, and laboratory regulation
Grain
Nutrition and diet
Prescription drugs
Gluten in Medicine Disclosure Act of 2013
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 17, 2013
Referred to the Subcommittee on Health.
May 15, 2013
Referred to the House Committee on Energy and Commerce.
May 15, 2013
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Gluten in Medicine Disclosure Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act to deem to be misbranded any drug intended for human use that contains an ingredient (other than a polyol) that constitutes or is derived from a grain or starch-containing ingredient and whose label fails to include a parenthetical statement identifying the source of the ingredient so constituted or derived.
What's happening now
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 2003: Gluten in Medicine Disclosure Act of 2013. 113th Congress. Open America. https://openamerica.io/bill/113-HR-2003/
"H.R. 2003: Gluten in Medicine Disclosure Act of 2013." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-HR-2003/.
H.R. 2003, 113th Cong. (2026), https://openamerica.io/bill/113-HR-2003/.
[H.R. 2003: Gluten in Medicine Disclosure Act of 2013](https://openamerica.io/bill/113-HR-2003/)